Baseline information at ICU admission included: demographic data, modified Charlson [16 (link)], Simplified Acute Physiology Score II (SAPS II) [17 (link)], SOFA score, underlying thyroid disease, triggering factors, clinical signs, and laboratory findings. Follow-up parameters recorded were the use of vasopressors, inotropic drugs, invasive mechanical ventilation, and renal replacement therapy. In addition, the composite diagnosis score of myxedema coma proposed by Popovenic et al. [18 (link)] which combines the presence or absence of alterations of thermoregulatory, central nervous systems, cardiovascular, gastrointestinal, and metabolic systems, and the presence or absence of a precipitating event, was applied in our cohort. Specific thyroid management (thyroid hormone replacement therapy) and corticosteroid use in ICU were also reported. Finally, survival at ICU discharge and 6-month survival status after ICU admission (through medical charts or contact by phone) was noted.
Free full text: Click here